Market View 28th February 2023

View on market: Stay Cautious, be with quality business:

Asia markets were set for a minor advance on Tuesday after the U.S. stocks managed to log small gains as investors digested further signs of economic strength, indicating that a path of tighter monetary policy lies ahead. Australian shares rose and futures contracts for equity benchmarks in Japan and Hong Kong climbed in line with the 0.3% advance for the S&P 500 on Monday. The tech-heavy Nasdaq 100 gained 0.7% as the two US indexes partly rebounded from swift declines Friday. Meanwhile, the yield on 10-year Treasuries advanced to 3.92%. Crude prices were trading around $82-mark, while Bitcoin was trading below 24,000-level. At 6:05 a.m., the Singapore-traded SGX Nifty, an early indicator of India’s benchmark Nifty 50, was unchanged at 17,487.5. India’s benchmark indices Sensex and Nifty ended down for the seventh straight day and hit a four-month low on Monday as metals, I.T., and auto stocks fell. Rupee continued to decline against the U.S. dollar amid speculations of further Fed rate hikes.

Economic Calendar:

• USD : ISM Manufacturing PMI (Feb) on 01^st March, 2023
• USD : Initial Jobless Claims on 02^nd March, 2023
• INR : GDP Quarterly (YoY) (Q3) on 28^th February, 2023
• INR : Federal Fiscal Deficit (Jan) on 28^th February, 2023

Brokerage Radar:

CITI ON MPHASIS: Sell. TP Rs 1705; Interacted with CFO; Deal TCV to rev conversion is slowing in current macro environment; Mortgage biz likely to remain muted in 4Q; Overall growth will likely improve post 4Q; On margins, guided range of 15.25% to 17% in FY23E

GS ON VOLTAS: Sell, TP Rs 840; Stock up 15% in last 15 days on newsflow around an early onset of summer in India; Voltas stk tends to outperform during onset of summer

Also, even during peak warm years industry growth has remained at a CAGR of 6-8% over last 10-15 yrs

NOMURA ON CROMPTON CONS: Buy, TP Rs 377; Co’s R&D center came up in 2019 & is ramping up; Benefits of these will start flowing over next few yrs In near term, believe margins could be slightly impacted due to price cut in pumps & increased marketing expenses

International Markets:

U.S & Europe

Asian markets

ADR Watch:

Commodities & Currency

FIIs & DIIs:

News Update:

Wipro: Announced four strategic global business lines—Wipro FullStride Cloud, Wipro Enterprise Futuring, Wipro Engineering Edge, and Wipro Consulting— to deepen alignment to evolving client needs.

NHPC: The Cabinet approved Rs 1,600 crore for pre-investment activities and various clearances for the Dibang Multipurpose Project being developed by the company in Arunachal Pradesh.

Zee Entertainment Enterprises: The exchanges reverted surveillance actions against the company after NCLAT stayed insolvency proceedings against it. With this, the exclusion of Zee from futures and options segment stands withdrawn and F&O contracts with May 2023 expiry to be made available from Feb. 28.

Infosys: Company rolled out private 5G-as-a-Service for enterprise clients worldwide.

Vodafone Idea: The board allotted 12,000 optionally convertible debentures of the face value of Rs 10 lakh each, aggregating to Rs 1200 crore, to ATC Telecom Infrastructure.

Godrej Industries: The company appointed Vishal Sharma as the CEO-designate of the chemicals business of Goderej Industries, with effect from March 1, 2023.

Mastek: Announced strategic partnership with Netail to help e-commerce and omni-channel retailers optimise their retail value-chain in order to attract, convert, and retain digital consumers.

Indiabulls Real Estate: Appointed president Sachin Chittaranjan Shah as executive director of the company for a tenure of five years, effective Feb. 27, 2023. Shyamm Mariwala, Javed Faizullah Tapia and Tarana Suresh Lalwani have been appointed as additional independent directors.

Dr. Reddy’s Laboratories: The company entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Australia-based Mayne Pharma.

 Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL